Name: Protalix BioTherapeutics, Inc. (PLX) Balance Sheet
Creator: FinSpry

Protalix BioTherapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Protalix BioTherapeutics, Inc. (PLX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	19.76	23.63	17.11	38.99	18.27	17.79	37.81
Short-Term Investments	15.07	20.93	5.07	0.00	20.28	0.00	0.00
Cash & Short-Term Investments	34.83	44.56	22.18	38.99	38.55	17.79	37.81
Accounts Receivable	2.91	5.27	4.59	3.44	2.77	4.70	4.73
Inventory	21.24	19.05	16.80	17.95	13.08	8.16	8.57
Other Current Assets	0.60	0.61	0.54	0.38	0.84	1.83	0.86
Total Current Assets	60.08	69.93	44.88	61.67	55.72	32.48	52.98
Non-Current Assets
Property, Plant & Equipment (Net)	10.02	10.88	9.64	9.92	10.41	10.97	6.39
Other Non-Current Assets	0.46	0.53	1.27	2.08	1.80	0.00	0.00
Total Non-Current Assets	13.34	14.50	10.91	12.00	32.49	12.94	8.15
Total Assets	73.42	84.43	55.79	73.67	67.93	45.42	61.13
Current Liabilities
Accounts Payable	4.53	4.32	5.86	6.99	7.22	18.40	13.83
Short-Term Debt	1.50	20.25	0.00	0.00	58.51	0.00	0.00
Current Portion of Long-Term Debt	0.00	20.25	0.00	0.00	58.51	0.00	0.00
Accrued Liabilities	11.17	14.43	9.56	14.41	13.61	0.00	0.00
Deferred Revenue	0.00	0.00	13.18	8.55	5.39	0.00	0.00
Other Current Liabilities	16.11	3.48	1.22	0.10	0.32	0.00	0.00
Total Current Liabilities	25.62	45.53	32.43	33.18	86.47	40.18	25.35
Non-Current Liabilities
Long-Term Debt	4.03	4.62	28.19	27.89	4.47	55.49	47.97
Other Non-Current Liabilities	0.56	0.00	0.00	0.00	0.05	0.51	5.29
Total Non-Current Liabilities	4.59	5.34	34.00	46.53	8.50	75.54	88.66
Total Liabilities	30.21	50.87	66.43	79.70	94.97	115.71	114.01
Stockholders' Equity
Common Stock	0.08	0.07	0.05	0.05	0.04	0.00	0.00
Retained Earnings	-378.39	-381.55	-389.86	-374.93	-347.35	-340.83	-322.55
Additional Paid-in Capital	421.53	415.05	379.17	368.85	320.28	270.49	269.66
Shares Outstanding	75.85	72.95	53.79	45.56	0.00	0.00	0.00
Total Stockholders' Equity	43.21	33.57	-10.64	-6.04	-27.04	-70.32	-52.88
Total Liabilities & Equity	73.42	84.43	55.79	73.67	67.93	45.42	61.13